1-(7-Bromo-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone, 95.0%, 500mg

5-Amino-2-methyl-1H-pyrrolo[2,3-b]pyridine, 97.0%, 1g

Agar polimixina mannitolo tuorlo d'uovo (base)

3-ethyl-3-piperidinecarboxamide hydrochloride, 95.0%, 5g

(R)-Tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione, 250mg

[2,2'-Bithiophen]-5-ylboronic acid, 95.0%, 1g

Capillare per punto di fusione, 80 mm, 1.55 mm, 1.15 mm, 1000 Pezzo(i)

3-(difluoromethyl)-1,2-dihydropyridin-2-one, 95%, 250mg

3-Bromomethyl-1-methyl-piperidine Hydrobromide, 95.0%, 1g

2-Bromo-4-pyridinecarboxaldehyde>95.0%(GC)1g

2-(3-CHLORO-4-CYCLOPROPYLPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95%, 100mg

Ethyl 7-chloro-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylate, 97%, 100mg

(2E)-3-(3-fluorophenyl)-1-(4-nitrophenyl)prop-2-en-1-one, 95.0%, 2g